ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

HRMY Harmony Biosciences Holdings Inc

31,69
1,42 (4,69%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Harmony Biosciences Holdings Inc HRMY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
1,42 4,69% 31,69 01:51:22
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
30,92 30,34 31,82 31,69 30,27
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202413:05GLOBEHarmony Biosciences Reports Strong First Quarter Financial..
30.4.202413:00PRNUSHarmony Biosciences Acquires Epygenix Therapeutics, Inc.,..
16.4.202414:05PRNUSHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL..
11.4.202414:05PRNUSHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP..
03.4.202414:05PRNUSHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL..
26.3.202413:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM..
11.3.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:21EDGAR2Form 144 - Report of proposed sale of securities
28.2.202423:16EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28.2.202414:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR..
22.2.202422:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.2.202414:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202413:45EDGAR2Form 8-K - Current report
22.2.202413:30GLOBEHarmony Biosciences Reports Fourth Quarter and Full Year..
21.2.202414:05PRNUSU.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO..
20.2.202414:05PRNUSHARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG..
14.2.202401:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202414:05PRNUSHARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR..
26.1.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
26.1.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202414:30EDGAR2Form 8-K - Current report
08.1.202414:05PRNUSHARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND..
03.1.202414:05PRNUSHARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P...
07.12.202322:06EDGAR2Form 8-K/A - Current report: [Amend]
07.12.202314:05PRNUSHARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM..
05.12.202314:05PRNUSHARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY..
16.11.202314:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th..
15.11.202314:05PRNUSHARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING..
08.11.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202314:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.11.202314:30EDGAR2Form 8-K - Current report
08.11.202314:05PRNUSHARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD..
31.10.202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.10.202312:45EDGAR2Form 8-K - Current report
31.10.202312:30GLOBEHarmony Biosciences Reports Strong Third Quarter 2023..
26.10.202314:05PRNUSHARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE..
17.10.202314:05PRNUSHARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL..
13.10.202314:15EDGAR2Form 8-K - Current report
13.10.202314:00PRNUSHARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3..
11.10.202314:15EDGAR2Form 8-K - Current report
11.10.202314:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
05.10.202322:15EDGAR2Form 8-K - Current report
05.10.202314:05PRNUSHARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM..
04.10.202314:00EDGAR2Form 8-K - Current report
27.9.202314:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
25.9.202314:00EDGAR2Form 8-K - Current report
20.9.202314:05PRNUSHARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D.,..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock